Kevin Puylaert - 05 Oct 2026 Form 4 Insider Report for SOPHiA GENETICS SA (SOPH)

Reporting relationship: Chief Sales Officer
Issuer ticker: SOPH
Reported as of: 05 Oct 2026
Net transaction value: -$1,737
SEC form: 4
Accepted by SEC: 07 Oct 2026, 16:04:25 UTC
Prior SEC filing: 07 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Elimara Brunetto as Attorney-in-fact for Kevin Puylaert

Key filing fact

Kevin Puylaert filed Form 4 for SOPHiA GENETICS SA (SOPH) on 07 Oct 2026.

Key facts

This page summarizes Kevin Puylaert's Form 4 filing for SOPHiA GENETICS SA (SOPH).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Oct 2026, 16:04.

Change

Previous filing in this sequence was filed on 07 Jul 2026.
Current net transaction value: -$1,737.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002119354 Primary reporting owner

Puylaert Kevin

Relationship: Chief Sales Officer
Address: C/O SOPHIA GENETICS SA, LA PIECE 12, ROLLE, SWITZERLAND
Signature: /s/ Elimara Brunetto as Attorney-in-fact for Kevin Puylaert
Signature date: 07 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SOPH transaction

Ordinary Shares

Sale

Transaction value: $1,491
Shares: -185
Change %: -0.13%
Price: $8.06
Shares after: 147,763
Date: 05 Oct 2026
Ownership: Direct
Footnotes: F1

SOPH transaction

Ordinary Shares

Sale

Transaction value: $246
Shares: -31
Change %: -0.02%
Price: $7.92
Shares after: 147,732
Date: 05 Oct 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 2, 2026.

Footnote F2

Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 3, 2026.